Drug Type Antibody drug conjugate (ADC) |
Synonyms AT 06 (Axcynsis Therapeutics), AT06 (Axcynsis Therapeutics) |
Target |
Action inhibitors |
Mechanism DLL3 inhibitors(Delta-like protein 3 inhibitors), SEZ6 inhibitors(seizure related 6 homolog inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | Singapore | 25 Mar 2024 |






